Laboratory Corporation of America Holdings (NYSE:LH) in our automated value investing analysis, with the cash flow history and price comparison below.
Advertisement helps keep Trendshare free for most readers.
Estimate how long you need to hold Laboratory Corporation of America Holdings to reach your target.
Based on historical returns, we believe that Laboratory Corporation of America Holdings can grow its free cash at a rate of about 7%. That's positive!
| Advantages | Disadvantages | Neutral |
|---|---|---|
|
|
|
| LH Price (Laboratory Corporation of America Holdings stock price per share) |
$370.78 | |
|
|
LH Fair Price (based on intrinsic value) |
$381.25 |
| LH Safety Price (based on a variable margin of safety) | $305.00 | |
|
Try your own return
The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value. Value per share: |
||
| PE Ratio versus Sector | 61% lower than other Unknown stocks | |
| PE Ratio versus Industry | 93% lower than other Unknown stocks | |
| Cash Yield | 3.93% | |
| Free Cash Flow Jitter | 39% | |
| Dividend Yield | 0.78% (tax impact) | Shares Shorted | 2,544,414 |
No open-market insider buys or sells are recorded for the last 12 months.
This stock has short interest! This means that people have shorted it.
Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.
As of the latest analysis, there are 2,544,414 shares shorted. With 80,819,984 shares available for purchase and an average trading volume over the past 10 trading days of 647,770, it would take at least 3.9 days for all of the short holders to cover their shorts.
Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth
Each year names the SEC filer that reported it, so a change of filer shows up here.
| Fiscal year | SEC filer (CIK) | Free cash flow (USD millions) |
|---|---|---|
| 2007 | 920148 | 567.1 |
| 2008 | 920148 | 631.2 |
| 2009 | 920148 | 724.4 |
| 2010 | 920148 | 748.6 |
| 2011 | 920148 | 718.4 |
| 2012 | 920148 | 698.0 |
| 2013 | 920148 | 666.2 |
| 2014 | 920148 | 568.7 |
| 2015 | 920148 | 786.2 |
| 2016 | 920148 | 974.3 |
| 2017 | 920148 | 1247.4 |
| 2018 | 920148 | 1019.2 |
| 2019 | 920148 | 1119.2 |
| 2020 | 920148 | 1784.6 |
| 2021 | 920148 | 2730.4 |
| 2022 | 920148 | 1553.4 |
| 2023 | 920148 | 910.4 |
| 2024 | 920148 | 1150.6 |
| 2025 | 920148 | 1194.7 |
Download the yearly data as CSV.
Over the 19 fiscal years from 2007 to 2025 with positive net income, operating cash flow totaled $24673.8 million against net income of $15567.6 million, or 1.58 times.
In 2025, operating cash flow was 1.87 times net income, compared with 1.58 times for the earliest three years (2007 to 2009).
In 2025, capital expenditures were $434.5 million, 26.5% of operating cash flow of $1640.5 million, which leaves an estimated $1206.0 million after capex. Across the 19 years with reported capex, it averaged 22.3% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.
| Fiscal year | Net income (USD millions) | Operating cash flow (USD millions) | Capital expenditures (USD millions) | Operating cash flow / net income |
|---|---|---|---|---|
| 2007 | 476.8 | 709.7 | 142.6 | 1.49 |
| 2008 | 464.5 | 780.9 | 156.7 | 1.68 |
| 2009 | 543.3 | 862.4 | 114.7 | 1.59 |
| 2010 | 558.2 | 883.6 | 126.1 | 1.58 |
| 2011 | 519.7 | 855.6 | 145.7 | 1.65 |
| 2012 | 583.1 | 841.4 | 173.8 | 1.44 |
| 2013 | 573.8 | 818.7 | 202.2 | 1.43 |
| 2014 | 511.2 | 739.0 | 203.5 | 1.45 |
| 2015 | 437.6 | 982.4 | 255.8 | 2.24 |
| 2016 | 711.8 | 1197.1 | 278.9 | 1.68 |
| 2017 | 1227.1 | 1498.1 | 312.9 | 1.22 |
| 2018 | 883.7 | 1305.4 | 379.8 | 1.48 |
| 2019 | 823.8 | 1444.7 | 400.2 | 1.75 |
| 2020 | 1556.1 | 2135.3 | 381.7 | 1.37 |
| 2021 | 2377.3 | 3109.6 | 421.5 | 1.31 |
| 2022 | 1279.1 | 1955.9 | 429.3 | 1.53 |
| 2023 | 418.0 | 1327.7 | 453.6 | 3.18 |
| 2024 | 746.0 | 1585.8 | 489.9 | 2.13 |
| 2025 | 876.5 | 1640.5 | 434.5 | 1.87 |
Revenue was $4068.2 million in 2007 and $13951.7 million in 2025, a compound annual growth rate of 7.1% over 18 years.
Revenue rose 7.2% from 2024 to 2025.
Our estimated free cash flow was $1194.7 million in 2025, 8.6% of revenue. In 2007 the estimated margin was 13.9%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.
| Fiscal year | Revenue (USD millions) | Estimated free cash flow (USD millions) | Estimated free cash flow / revenue |
|---|---|---|---|
| 2007 | 4068.2 | 567.1 | 13.9% |
| 2008 | 4505.2 | 631.2 | 14.0% |
| 2009 | 4694.7 | 724.4 | 15.4% |
| 2010 | 5003.9 | 748.6 | 15.0% |
| 2011 | 5542.3 | 718.4 | 13.0% |
| 2012 | 5671.4 | 698.0 | 12.3% |
| 2013 | 5808.3 | 666.2 | 11.5% |
| 2014 | 6011.6 | 568.7 | 9.5% |
| 2015 | 8680.1 | 786.2 | 9.1% |
| 2016 | 9552.9 | 974.3 | 10.2% |
| 2017 | 10308.0 | 1247.4 | 12.1% |
| 2018 | 11333.4 | 1019.2 | 9.0% |
| 2019 | 11554.8 | 1119.2 | 9.7% |
| 2020 | 13978.5 | 1784.6 | 12.8% |
| 2021 | 13136.1 | 2730.4 | 20.8% |
| 2022 | 11863.9 | 1553.4 | 13.1% |
| 2023 | 12161.6 | 910.4 | 7.5% |
| 2024 | 13008.9 | 1150.6 | 8.8% |
| 2025 | 13951.7 | 1194.7 | 8.6% |
In 2025, cash and equivalents were $532.3 million against total liabilities of $9772.9 million, or 5.4% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.
Total liabilities were 53.1% of total assets in 2025, compared with 61.2% in 2008, a decrease of 8.1 percentage points.
Stockholders equity was $8619.8 million in 2025, compared with $1809.6 million in 2008, a rise of 376.3%.
Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 7.9% in 2025. Invested capital here is total assets less cash and current liabilities.
| Fiscal year | Total assets (USD millions) | Cash and equivalents (USD millions) | Total liabilities (USD millions) | Stockholders equity (USD millions) |
|---|---|---|---|---|
| 2008 | 4669.5 | 219.7 | 2859.9 | 1809.6 |
| 2009 | 4837.8 | 148.5 | 2731.7 | 2106.1 |
| 2010 | 6187.8 | 159.3 | 3721.5 | 2466.3 |
| 2011 | 6111.8 | 159.3 | 3608.3 | 2503.5 |
| 2012 | 6795.0 | 404.0 | 1849.9 | 4945.1 |
| 2013 | 6965.9 | 404.0 | 4474.6 | 2491.3 |
| 2014 | 7301.8 | 580.0 | 4481.3 | 2820.5 |
| 2015 | 14104.7 | 716.4 | 9159.6 | 4945.1 |
| 2016 | 14247.0 | 433.6 | 8728.8 | 5518.2 |
| 2017 | 16673.0 | 316.6 | 9868.9 | 6804.1 |
| 2018 | 16185.3 | 426.8 | 9137.0 | 7048.3 |
| 2019 | 18046.4 | 337.5 | 10402.5 | 7643.9 |
| 2020 | 20071.7 | 1320.8 | 10635.1 | 9436.6 |
| 2021 | 20385.4 | 1472.7 | 10112.0 | 10273.4 |
| 2022 | 20155.1 | 320.6 | 10058.5 | 10096.6 |
| 2023 | 16725.1 | 536.8 | 8850.1 | 7875.0 |
| 2024 | 18379.0 | 1518.7 | 10326.8 | 8052.2 |
| 2025 | 18392.7 | 532.3 | 9772.9 | 8619.8 |
Free cash flow was positive in all 19 fiscal years we have for Laboratory Corporation of America Holdings under its current SEC filer.
The latest three years average $1085.3 million in free cash flow against $640.9 million for the earliest three, which is a sharp rise.
Year-to-year variability in free cash flow is volatile, measured at 39%.
Laboratory Corporation of America Holdings at $370.78 lies between its safe value ($305.00) and its fair value ($381.25).
Laboratory Corporation of America Holdings pays a dividend yield of 0.78%.
These figures are automated calculations from SEC filings and the recent price. They are not a recommendation to buy or sell. See how we estimate value.
Every fiscal year on this page is reported by one SEC filer, CIK 920148.
Each figure on this page comes from that filer.
Advertisement supports free stock analysis content.
Does Laboratory Corporation of America Holdings have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.
This example shows how we apply the Trendshare checklist to LH: earnings power, cash generation, valuation, and margin of safety.
We check: business quality, free cash flow, P/E, and margin of safety.
Most Popular Articles
What are Broker Fees (and how to pay less)?
What is Liquidity in Stocks and Financial Instruments?